RadNet, Inc. (RDNT) company profile
Close on Nov 13, 2026Market cap $6.01BP/E –Yield –
About RadNet
Services-Medical Laboratories, SIC 8071
RadNet provides diagnostic imaging services and digital healthcare solutions. The company operates through two primary business segments: Imaging Centers and Digital Health. Its core offerings include outpatient diagnostic imaging services, healthcare management services, medical software development, and specialized radiology technologies. RadNet serves patients, medical practices, and healthcare facilities. Its customer base and reimbursement sources comprise commercial health insurance providers, government programs such as Medicare and Medicaid, workers' compensation plans, and individuals covered under capitation and personal injury arrangements.
The company conducts operations primarily across the United States, maintaining a significant regional footprint in states such as California, Delaware, Florida, Maryland, New Jersey, and New York. RadNet expands its outpatient diagnostic network through local joint ventures, medical clinic partnerships, and acquisitions of imaging facilities. Beyond its domestic operations, the business maintains international activities and entities in the United Kingdom and the Netherlands. The provided annual report text does not state the specific location of the company's corporate headquarters or the exact total count of its imaging facilities.
Summary of the business section of RadNet's latest annual report, written by StockData.
Company profile
Company
- Legal name
- RadNet, Inc.
- Headquarters
- Los Angeles, CA
- Address
- 1510 Cotner Ave 90025
- Phone
- (310) 478-7808
- Website
- radnet.com
- Employees
- 76, Dec 31, 2018
- Industry
- Services-Medical Laboratories
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Los Angeles, California
Stock & identifiers
- Ticker
- RDNT
- Exchange
- Nasdaq
- IPO date
- Jan 3, 1997
- Shares outstanding
- 79M, Aug 6, 2026
- Public float
- $4.10B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 1-for-2 reverse, Nov 28, 2006
- SEC CIK
- 790526
- CUSIP
- 750491102
- ISIN
- US7504911022
- FIGI
- BBG000CXSF54
- Share class FIGI
- BBG001S75DK5
- LEI
- 529900RECG94V2IZJ970
- EIN
- 13-3326724
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Howard G. Berger | President, CEO, Director | 518,315 |
| Alma Gregory Sorensen | Chief Strategy Officer, Director | 1,218,351 |
| Mital Patel | EVP, Chief Operating Officer | 154,874 |
| Cornelis Wesdorp | Pres & CEO, Digital Health | 69,075 |
| Stephen M. Forthuber | Pres & CEO-Eastern Operations | 527,052 |
| Norman R. Hames | Pres and COO-West Operations | 284,217 |
| Michael N. Murdock | EVP, Mergers and Acquisitions | 46,697 |
| Mark Stolper | EVP, Chief Financial Officer | 121,943 |
| David Jeffrey Katz | EVP and Chief Legal Officer | 90,866 |
| Ranjan Jayanathan | Chief Information Officer | 138,198 |
| David L. Swartz | Director | 214,032 |
| Laura Pastre Jacobs | Director | 29,953 |
| Gregory E. Spurlock | Director | 8,236 |
| Lawrence L. Levitt | Director | 167,902 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $12.09M | $9.28M | $3.10M | $365 | $112 |
| FY2024 | $9.08M | $16.35M | $2.62M | $357 | $94 |
| FY2023 | $6.70M | $10.10M | $2.03M | $178 | $92 |
| FY2022 | $5.56M | $5.56M | $2.82M | $96 | $88 |
| FY2021 | $4.57M | $4.57M | $1.68M | $154 | $110 |
| FY2020 | $2.84M | $2.84M | $1.05M | $96 | $134 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer)(3) | $3.00M | – | $9.00M | $87.97K | $12.09M | +33% |
| Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | $700.00K | $350.00K | $1.75M | $33.52K | $2.83M | +50% |
| Stephen M. Forthuber President and Chief Operating Officer - Eastern Operations | $800.00K | $400.00K | $2.00M | $54.49K | $3.25M | +51% |
| Norman R. Hames President and Chief Operating Officer - Western Operations | $800.00K | $400.00K | $2.00M | $38.10K | $3.24M | +52% |
| Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | $750.00K | $375.00K | $1.87M | $55.59K | $3.06M | +56% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“eRAD has approximately 76 employees, including a research and development team of 21 software engineers in Budapest, Hungary.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?